SINGAPORE, June 6, 2023 PRNewswire Jun. 1st, 2023, Biosyngen Pte. Ltd. (hereinafter as Biosyngen) announced that the U.S. Food and Drug Administrations (FDA) Office of Orphan Products Dev
GUANGZHOU, China, Dec. 29, 2021 /PRNewswire/ The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore Guangzhou Knowledge City (CSGKC), on December 28th , 2021. Representatives from both countries celebrated the landmark achievement Government officials from Guangzhou Huangpu District and development district, General-Consulate of the Republic of Singapore.